Clinical Efficacy of Minimally Invasive Subpial Tonsillectomy(MIST) for Treatment of Chiari Malformation(Type Ⅰ) with Syringomyelia

被引:0
|
作者
Hao Li
Zhiqiang Cui
Yong Liu
机构
[1] Neurosurgery Department
[2] Yuquan Hospital of Tsinghua University
关键词
D O I
暂无
中图分类号
R651.2 [脊髓];
学科分类号
1002 ; 100210 ;
摘要
Background To investigate the clinical efficacy of minimally invasive subpial tonsillectomy(MIST) in the treatment of Chiari malformation(type I) with syringomyelia. Methods A total of 209 Chiari malformation(type I) patients with syringomyelia were studied. The patients were grouped based on the syrinx diameter changes: complete disappearance group(48 patients),obvious shrinkage group(147 patients), and non-obvious shrinkage group(14 patients). The Chicago Chiari Outcome Scale(CCOS) was used to compare clinical data of the three groups of patients before treatment. The correlations between disease duration and syrinx diameter changes as well as post-treatment clinical symptoms were analyzed. The related factors of efficacy were analyzed. Results Age and disease duration were the oldest/longest in the non-obvious shrinkage group, and the youngest/shortest in the complete disappearance group(P < 0.05). The maximum diameter reduction of syrinx was the greatest in the complete disappearance group, and the smallest in the non-obvious shrinkage group(P < 0.05). The proportions of patients with hypoesthesia, limb weakness, and muscle atrophy were the largest in the non-obvious shrinkage group, and the smallest in the complete disappearance group(P < 0.05). The CCOS score were the highest in the complete disappearance group, and the lowest in the non-obvious shrinkage group(P < 0.05). There were statistically significant(P < 0.05) negative correlations between disease duration and maximum diameter reduction of syrinx, CCOS pain score, CCOS non-pain score, CCOS functionality score, and CCOS complication score, disease duration and hypoesthesia, limb weakness, muscle atrophy, and sleep apnea. Result of multivariate stepwise regression analysis indicated that age, disease duration, and preoperative syrinx diameter were the risk factors for efficacy(P < 0.05). Conclusion For patients with Chiari malformation complicated by syringomyelia, the longer the disease duration, the more difficult it is to achieve syrinx reduction and improve the clinical symptoms.“Minimally invasive subpial tonsillectomy(MIST) and cisterna magna reconstruction” is an improved surgical approach to treat Chiari malformation(cerebellar tonsil herniation). It has the advantages of small incision, less postoperative reaction, and fewer complications, and it emphasizes the reshaping and repair of cerebellar tonsils, reconstruction of cisterna magna, and restoration of cerebrospinal fluid circulation.
引用
收藏
页码:310 / 321
页数:12
相关论文
共 50 条
  • [41] Management of Persistent Syringomyelia in Patients Operated for Chiari Malformation Type 1
    Aydin, Levent
    Dereli, Duygu
    Kartum, Tufan Agah
    Sirinoglu, Deniz
    Sahin, Balkan
    Eksi, Murat Sakir
    Musluman, Ahmet Murat
    Yilmaz, Adem
    WORLD NEUROSURGERY, 2024, 182 : E360 - E368
  • [42] The management of Chiari malformation type 1 and syringomyelia in children: a review of the literature
    Veronica Saletti
    Mariangela Farinotti
    Paola Peretta
    Luca Massimi
    Palma Ciaramitaro
    Saba Motta
    Alessandra Solari
    Laura Grazia Valentini
    Neurological Sciences, 2021, 42 : 4965 - 4995
  • [43] Recrudescence of the syringomyelia after surgery of Chiari malformation type 1 with duraplasty
    Yolas, Coskun
    Kanat, Ayhan
    BRITISH JOURNAL OF NEUROSURGERY, 2020, 34 (06) : 697 - 700
  • [44] Clinical Application of Diagnostic Imaging of Chiari-Like Malformation and Syringomyelia
    Rusbridge, Clare
    Stringer, Felicity
    Knowler, Susan P.
    FRONTIERS IN VETERINARY SCIENCE, 2018, 5
  • [45] Spontaneous Regression of Syringomyelia in a Young Patient with Chiari Type I Malformation
    Tortora, F.
    Napoli, M.
    Caranci, F.
    Cirillo, M.
    Pepe, D.
    Cirillo, S.
    Briganti, F.
    NEURORADIOLOGY JOURNAL, 2012, 25 (05): : 593 - 597
  • [46] The management of Chiari malformation type 1 and syringomyelia in children: a review of the literature
    Saletti, Veronica
    Farinotti, Mariangela
    Peretta, Paola
    Massimi, Luca
    Ciaramitaro, Palma
    Motta, Saba
    Solari, Alessandra
    Valentini, Laura Grazia
    NEUROLOGICAL SCIENCES, 2021, 42 (12) : 4965 - 4995
  • [47] Syringomyelia associated with Chiari type I malformation. Case report
    Garcia Leonard, Juan Ibrahim
    Sanchez Lozano, Ada
    Valladares Valle, Masleidy
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2020, 18 (06): : 1210 - 1215
  • [48] A genetic hypothesis for Chiari type 1 malformation with or without syringomyelia.
    Speer, MC
    Enterline, DS
    George, TM
    Frankin, A
    Mehltretter, L
    Wolpert, CM
    Milhorat, TH
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 386 - 386
  • [49] Progressive spontaneous regression of Chiari type I malformation associated with syringomyelia
    Correa, Diogo Goulart
    da Cruz Jr, Luiz Celso Hygino
    CHILDS NERVOUS SYSTEM, 2025, 41 (01)
  • [50] Pediatric syringomyelia with Chiari malformation: Its clinical characteristics and surgical outcomes
    Hida, K
    Iwasaki, Y
    Koyanagi, I
    Abe, H
    SURGICAL NEUROLOGY, 1999, 51 (04): : 383 - 390